DDIT3 and Hepatic fibrosis: Since we demonstrated that CHOP-induced pro-apoptotic pathways are involved in cholestatic liver damage and fibrosis, and as TUDCA is known to be able to modulate these pathways in other diseases [25,27,39], we investigated its therapeutic potential to impede liver fibrosis in the CBDL mouse model.